Literature DB >> 19526867

[Peculiarities of uric acid balance disorders in patients with type 2 diabetes and metabolic syndrome].

V V Korpachev, N M Hurina, T I Korpacheva, A A Shuprovych, I O Mosendz.   

Abstract

Hyperuricemia (HU) is considered to be a sign of metabolic syndrome as a consequence of purine metabolism disorder. To investigate alterations in uric acid (UA) methabolism, 90 subjects (M/F 53/37, aged 58 +/- 4 yr) with type 2 diabetes mellitus (DM2) were divided into 5 groups depending on the amount of excreted UA and its content in blood plasma. HU was found in 29% of patients, while hyperpoduction of UA was characteristic in 87% patients. Normo- or hypouricemia in majority of patients were mostly connected to kidney hyperfiltration and "compensatory" hyperuricosuria. HU with decreased UA excretion ("kidney" HU) was characteristic of severe DM2 with reduced kidney filtration rate. "Metabolic" HU with increased formation and excretion rated of UA was observed only in obese men. Increased insulinemia levels and insulin resistance index (IR) were found in obese patients in comparison with subjects with normal weight, independently of the type of UA excretion disorder. IR strongly correlated with serum UA levels in all groups of patients. The results suggest the significance of insulin resistance and abdominal obesity in UA metabolism in DM2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19526867

Source DB:  PubMed          Journal:  Fiziol Zh        ISSN: 2522-9028


  2 in total

1.  Is there a link between hyperuricemia, morning blood pressure surge, and non-dipping blood pressure pattern in metabolic syndrome patients?

Authors:  Emre Tutal; Burak Sayın; Derun Taner Ertugrul; Avsin Ibis; Siren Sezer; Nurhan Ozdemir
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-04-26

2.  Hyperuricaemia is associated with dyslipidemia but not HbA1c among type 2 diabetes mellitus patients in Botswana.

Authors:  Ellen Gobusamang; Naledi G Nyepetsi; Modisa S Motswaledi; Ishmael Kasvosve
Journal:  Afr J Lab Med       Date:  2019-11-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.